Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.
India could be a leader in shared mobility by 2030, providing opportunities for electric and autonomous vehicles. * Focus is shifting to electric vehicles to reduce emissions. * By 2030, the Indian ...
According to a study by Coherent market Insights, and is expected to grow at a CAGR of 11.3% in terms of revenue over the forecast period (2024-2031). Mr. Shah Coherent Market Insights Pvt. Ltd. +1 ...
India Today on MSN6d
How a Rs 72 lakh drug for a rare genetic disease could cost just Rs 3,000A drug cost analysis expert reveals that the life-saving drug Risdiplam, used to treat the rare genetic disease SMA, could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback